Phase 2Not yet recruiting

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease

Sponsor
National Institute on Aging (NIA) (NIH)
Enrolment
200 planned
Conditions
Alzheimer's Disease
Interventions
Psilocybin; Cognitive Training
Ages
older adults
Registry
NCT07721467

From the registry

Background: Normal aging, as well as dementias such as Alzheimer s disease, can cause changes in the brain that affect memory, attention, and thinking. Researchers want to know if regular mental tasks (cognitive training) can improve brain function in older adults. They also want to know if psilocybin, a compound found in certain mushrooms, can further support improved brain function. Objective: To learn how regular cognitive training, with or without psilocybin, can improve brain health in older adults. Eligibility: People aged 65 years and older with mild cognitive impairment or early-stage Alzheimer s disease. Healthy older adults with normal cognition are also needed. Design: Participants will be screened. They will have a test of their heart function and an imaging scan. They will have mental health screening and tests of their thinking and memory. They will practice brain-training tasks on a tablet. Participants will be divided into 2 groups: 1 will have cognitive training plus psilocybin; 1 will have cognitive training only. Those having cognitive training only will…

Primary outcomes

  • Determine whether psilocybin enhances neuroplasticity (Neuroplasticity Composite Score (NPCS))
Full record on ClinicalTrials.gov